AWARD AMOUNT*
$50,000 per project per year for up to two years
POSTED DATE
Friday, September 25, 2020
DEADLINE FOR APPLICATION
Friday, October 30, 2020 | 5:00 p.m. EDT
ANTICIPATED AWARD DATE
Monday, January 4, 2021
The Cancer Program of the Harvard Stem Cell Institute (HSCI) invites applications for pilot grants to be awarded for research in 2021. The intent is to provide resources for innovative projects dissecting stem/developmental programs in solid tumors that would help foster collaborations within the HSCI research community. This funding is for innovative, high-impact research projects and is designed to provide a foundation of more substantial initiatives at R01 and P01 levels. Multi-investigator, multi-institution proposals are encouraged, as are new technologies such as single-cell genomics and tumor organoids. The applications should promote the Program mission: To identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence may serve as candidate targets for therapy.
*Up to two (2) projects will be funded for at a maximum of $100,000 each, or one (1) collaborative project between multiple PIs will be funded at a maximum of $200,000. All personnel, including the PI, must commit effort, even if salary is not requested.
HSCI plans to award two (2) grants yet reserves the right not to fund any project. Each project will receive two years of funding ($50,000 per year). Decision on the duration and level of funding will be made by the HSCI Executive Committee, following advice from an ad hoc committee appointed to review all applications. For projects that are awarded two years of funding, the second year is contingent on achievement of milestones specified for the first year and will be at the discretion of the HSCI Executive Committee. | hsci_cancerpilotgrantsrfp2021_final-25092020_01.pdf | 174 KB |